- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Visceral Medicine 31.4 (2015): S. 287-289.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2015
- Urheber
- URN
-
urn:nbn:de:bvb:29-opus4-122396
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lamprecht, Georg
- Atreya, Raja
- Kreis, Martin E.
- Siegmund, Britta
- Stallmach, Andreas
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2015
Ähnliche Objekte (12)
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Immunsuppressive Therapie bei chronisch entzündlichen Darmerkrankungen
Immunsuppressive Therapie bei chronisch entzündlichen Darmerkrankungen
Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab
Focus acute and chronic infections of the gastrointestinal tract
CED in der Praxis - Therapie
CED in der Praxis - Klinik und Medikation
Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies
Pathophysiology of IBD as a Key Strategy for Polymeric Nanoparticle Development
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Immunsuppressive Therapie bei chronisch entzündlichen Darmerkrankungen
Immunsuppressive Therapie bei chronisch entzündlichen Darmerkrankungen
Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab
Focus acute and chronic infections of the gastrointestinal tract
CED in der Praxis - Therapie
CED in der Praxis - Klinik und Medikation
Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies
Pathophysiology of IBD as a Key Strategy for Polymeric Nanoparticle Development
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Immunsuppressive Therapie bei chronisch entzündlichen Darmerkrankungen
Immunsuppressive Therapie bei chronisch entzündlichen Darmerkrankungen
Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab
Focus acute and chronic infections of the gastrointestinal tract
CED in der Praxis - Therapie
CED in der Praxis - Klinik und Medikation
Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies